SPRB - Spruce Biosciences, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Daly City,
United States
Type: Equity
SPRB price evolution
SPRB
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $96.34 | $98.8 | $97.48 | $73.93 |
| Short term investments | $9.23 | $23.04 | $44.66 | |
| Net receivables | $15 | |||
| Inventory | ||||
| Total current assets | $102.18 | $111.14 | $124.13 | $137.24 |
| Long term investments | ||||
| Property, plant & equipment | $1.18 | $1.24 | $1.3 | $1.35 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.76 | $1.85 | $1.83 | $1.88 |
| Total investments | $9.23 | $23.04 | $44.66 | |
| Total assets | $103.95 | $112.98 | $125.96 | $139.11 |
| Current liabilities | ||||
| Accounts payable | $3.33 | $3.15 | $0.94 | $3.45 |
| Deferred revenue | $4.91 | $7.8 | $10.87 | $13.04 |
| Short long term debt | $1.62 | $1.62 | $1.62 | $1.62 |
| Total current liabilities | $24.46 | $24.19 | $22.73 | $23 |
| Long term debt | $2.74 | $3.2 | $3.65 | $4.11 |
| Total noncurrent liabilities | $2.97 | $3.42 | $6.67 | $8.12 |
| Total debt | $4.36 | $4.82 | $5.28 | $5.73 |
| Total liabilities | $27.44 | $27.6 | $29.4 | $31.12 |
| Shareholders' equity | ||||
| Retained earnings | -$197.23 | -$187.28 | -$174.93 | -$162.1 |
| Other shareholder equity | -$0 | -$0.06 | -$0.19 | |
| Total shareholder equity | $76.51 | $85.38 | $96.56 | $108 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $96.34 | $24.49 | $42.96 | $157.37 |
| Short term investments | $54.59 | $46.22 | ||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $102.18 | $83.61 | $91.89 | $160.4 |
| Long term investments | $32.46 | |||
| Property, plant & equipment | $1.18 | $1.4 | $1.48 | $1.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.76 | $2.04 | $34.59 | $2.49 |
| Total investments | $54.59 | $78.68 | ||
| Total assets | $103.95 | $85.65 | $126.49 | $162.88 |
| Current liabilities | ||||
| Accounts payable | $3.33 | $1.43 | $2.82 | $3.63 |
| Deferred revenue | $4.91 | |||
| Short long term debt | $1.62 | $1.62 | $2.55 | |
| Total current liabilities | $24.46 | $12.45 | $8.87 | $9.76 |
| Long term debt | $2.74 | $3.29 | $6.17 | $3.58 |
| Total noncurrent liabilities | $2.97 | $4.71 | $6.24 | $3.69 |
| Total debt | $4.36 | $6.18 | $6.17 | $6.13 |
| Total liabilities | $27.44 | $17.16 | $15.12 | $13.46 |
| Shareholders' equity | ||||
| Retained earnings | -$197.23 | -$149.31 | -$103.13 | -$60.84 |
| Other shareholder equity | -$0.56 | -$0.18 | ||
| Total shareholder equity | $76.51 | $68.49 | $111.37 | $149.43 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.89 | $3.07 | $2.17 | $1.96 |
| Cost of revenue | ||||
| Gross Profit | $2.89 | $3.07 | $2.17 | $1.96 |
| Operating activities | ||||
| Research & development | $11.1 | $13.49 | $13.13 | $11.71 |
| Selling, general & administrative | $2.95 | $3.24 | $3.01 | $3.45 |
| Total operating expenses | $14.05 | $16.73 | $16.14 | $15.16 |
| Operating income | -$11.16 | -$13.66 | -$13.97 | -$13.2 |
| Income from continuing operations | ||||
| EBIT | -$9.84 | -$12.23 | -$12.7 | -$12.66 |
| Income tax expense | ||||
| Interest expense | $0.11 | $0.12 | $0.13 | $0.13 |
| Net income | ||||
| Net income | -$9.95 | -$12.35 | -$12.82 | -$12.79 |
| Income (for common shares) | -$9.95 | -$12.35 | -$12.82 | -$12.79 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10.09 | |||
| Cost of revenue | ||||
| Gross Profit | $10.09 | |||
| Operating activities | ||||
| Research & development | $49.43 | $35.2 | $30.7 | $23.85 |
| Selling, general & administrative | $12.65 | $12.09 | $11.37 | $5.56 |
| Total operating expenses | $62.08 | $47.28 | $42.07 | $29.42 |
| Operating income | -$51.99 | -$47.28 | -$42.07 | -$29.42 |
| Income from continuing operations | ||||
| EBIT | -$47.44 | -$45.76 | -$41.95 | -$29.22 |
| Income tax expense | ||||
| Interest expense | $0.48 | $0.42 | $0.34 | $0.32 |
| Net income | ||||
| Net income | -$47.92 | -$46.18 | -$42.29 | -$29.54 |
| Income (for common shares) | -$47.92 | -$46.18 | -$42.29 | -$29.54 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$9.95 | -$12.35 | -$12.82 | -$12.79 |
| Operating activities | ||||
| Depreciation | $0.07 | $0.07 | $0.07 | $0.08 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.22 | $1.12 | $1.22 | $1.06 |
| Total cash flows from operations | -$11.21 | -$12.27 | $1.99 | -$11.79 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | |||
| Investments | $9.3 | $14 | $22 | $10.48 |
| Total cash flows from investing | $9.3 | $13.99 | $22 | $10.48 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.07 | $0.1 | $53.62 | |
| Net borrowings | -$0.41 | -$0.41 | -$0.41 | -$0.41 |
| Total cash flows from financing | -$0.55 | -$0.41 | -$0.43 | $50.53 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.46 | $1.32 | $23.56 | $49.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$47.92 | -$46.18 | -$42.29 | -$29.54 |
| Operating activities | ||||
| Depreciation | $0.3 | $0.43 | $0.38 | $0.1 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.62 | $3.63 | $3.96 | $0.76 |
| Total cash flows from operations | -$33.27 | -$41.68 | -$35.88 | -$27.52 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.01 | -$0.09 | -$0.07 |
| Investments | $55.78 | $23.7 | -$79.08 | |
| Total cash flows from investing | $55.78 | $23.69 | -$79.17 | -$0.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $53.79 | $0.08 | $0.46 | $96.31 |
| Net borrowings | -$1.62 | $0.22 | ||
| Total cash flows from financing | $49.14 | -$0.24 | $0.64 | $181.03 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $71.64 | -$18.23 | -$114.4 | $153.44 |
News
Fundamentals
| Market cap | $34.18M |
|---|---|
| Enterprise value | -$57.80M |
| Shares outstanding | 41.03M |
| Revenue | $10.09M |
|---|---|
| EBITDA | -$47.14M |
| EBIT | -$47.44M |
| Net Income | -$47.92M |
| Revenue Q/Q | InfinityT% |
| Revenue Y/Y | N/A |
| P/E ratio | -0.71 |
|---|---|
| EV/Sales | -5.73 |
| EV/EBITDA | 1.23 |
| EV/EBIT | 1.22 |
| P/S ratio | 3.39 |
| P/B ratio | 0.45 |
| Book/Share | 1.86 |
| Cash/Share | 2.35 |
| EPS | -$1.17 |
|---|---|
| ROA | -39.77% |
| ROE | -52.31% |
| Debt/Equity | 0.36 |
|---|---|
| Net debt/EBITDA | 1.46 |
| Current ratio | 4.18 |
| Quick ratio | 4.18 |